Diane Rother
Adult Health · Levittown, PANPI 1386935757
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 662 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 51 manufacturers reported payments, led by AbbVie at 24.6% of the total. Reporting peaked in 2021 at $2,826 and has fallen 58.6% since, to $1,170 in 2025. Among adult health clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 662 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Pfizer$1K
- Novo Nordisk$813
- Lilly USA, LLC$752
- GSK$725
- AstraZeneca$629
- plus $4K from 45 others
What the payments were for
- Food & beverage$10,519100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,519 in reported general payments places this provider in the 95th percentile of 899 adult health providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 51 | $51,756 |
| EliquisApixaban | 50 | $47,834 |
| TrulicityDulaglutide | 32 | $38,515 |
| JardianceEmpagliflozin | 30 | $31,393 |
| XareltoRivaroxaban | 18 | $29,237 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 45 | $28,337 |
| FarxigaDapagliflozin Propanediol | 14 | $21,076 |
| Breo ElliptaFluticasone/Vilanterol | 34 | $13,422 |
| JanumetSitagliptin Phos/Metformin Hcl | 15 | $8,278 |
| MyrbetriqMirabegron | 14 | $7,887 |
| JanuviaSitagliptin Phosphate | 13 | $7,167 |
| Valsartan | 125 | $4,813 |
| Levothyroxine Sodium | 274 | $4,538 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 24 | $4,458 |
| Atorvastatin Calcium | 293 | $3,598 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $813 | $51,75651 claims |
| PfizerEliquis | $1,176 | $47,83450 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $725 | $41,76079 claims |
| Lilly USA, LLCTrulicity | $752 | $38,51532 claims |
| Boehringer IngelheimJardiance | $300 | $31,39330 claims |
| Johnson & JohnsonXarelto | $98 | $29,23718 claims |
| AstraZenecaFarxiga | $629 | $21,07614 claims |
| MerckJanumet, Januvia | $276 | $15,44528 claims |
| Astellas Pharma US IncMyrbetriq | $74 | $7,88714 claims |
| AbbVieSynthroid | $2,585 | $3,40534 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 899 adult health providers in Pennsylvania.
Other adult health in Levittown
- Beth SandyPhiladelphia$924K
- Jennifer MondilloSchwenksville$396K
- Diane NewmanPhiladelphia$343K
- Elizabeth FaustDouglassville$342K
- Abigail SmithPhiladelphia$302K
- Jean CainAllentown$214K
- Jennifer KeeleyWexford$97K
- Debra EvansFarrell$85K
- Bethann MallonBlue Bell$65K
- Catherine HoldsworthPhiladelphia$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.